Find out about program updates, news features, and families helped by newborn screening.
Each facility is responsible for selecting the cCMV test that will be used. Per section 383.145, F.S., a test approved by the U.S. Food and Drug Administration (FDA) or another diagnostically equivalent test can be used to test for cCMV. FDA approved tests can be found using the Clinical Laboratory Improvement Amendments search database at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCLIA/search.cfm.
The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that as of January 2025, all newborns are being screened for Guanidinoacetate methyltransferase (GAMT) deficiency through the newborn screening process. If you have any questions, please contact …
The Florida Department of Health, Newborn Screening (NBS) Program, is pleased to announce that beginning July 1, 2024, all newborns screened will be tested for Mucopolysaccharidosis Type II (MPS II). If you have any questions, please contact the Florida NBS …
The Florida Newborn Hearing Screening/Early Hearing Detection and Intervention Program is pleased to announce that beginning December 9, 2021, the Florida Guidelines for Newborn Hearing Screening have been revised. For more information or questions about hearing screenings or the revised …